PTEN/MMAC1 (phosphatase, tensin homologue/mutated in multiple advanced canc
ers) is a tumor suppressor protein that has sequence homology with dual-spe
cificity phosphatases, which ave capable of dephosphorylating both tyrosine
phosphate and serine/threonine phosphate residues on proteins, The in vivo
function of PTEN/MMAC1 appears to be dephosphorylation of phosphotidylinos
itol 3,4,5-triphosphate, The PTEN/MMAC1. gene is mutated in the germline! o
f patients with rare autosomal dominant cancer syndromes and in subsets of
specific cancers. Here we review the mutational spectra of the PTEN/MMAC1 g
ene in tumors from various tissues, especially endometrium, brain, prostate
, and ovary, in which the gene is inactivated very frequently, Germline and
somatic mutations in the PTEN/MMAC1 gene occur mostly in the protein codin
g region and involve the phosphatase domain and poly(A)(6) stretches. Compa
red with germline alterations found in the PTEN/MMAC1 gene, there is a subs
tantially increased frequency of frameshift mutations in tumors. Glioblasto
mas and endometrial carcinomas appear to have, distinct mutational spectra,
probably reflecting differences in the underlying mechanisms of inactivati
on of the PTEN/MMAC1 gene in the two tissue types. Also, depending on the t
issue type, the gene appears to be involved in the initiation or the progre
ssion of cancers. Further understanding of PTEN/MMAC1 gene mutations in dif
ferent tumors and the physiologic consequences of these mutations is likely
to open up new therapeutic opportunities for targeting this critical gene.